| abstract |
Pharmaceutical composition for the treatment of inflammations of the oral cavity, in particular foot-and-mouth disease, characterized in that it contains a soluble extract of tea as an active principle, as well as a pharmaceutically acceptable vehicle capable of ensuring prolonged contact between the active ingredient and the oral cavity. The vehicle is advantageously constituted by a chewing gum. |